Beneficial effects of Etanercept on experimental necrotizing enterocolitis

Pediatric Surgery International

Volumn 30, Issue 1, 2014, Pages 71-77

  Yurttutan, Sadik ^a   Ozdemir, Ramazan ^b   Canpolat, Fuat Emre ^a   Oncel, Mehmet Yekta ^a   Unverdi, Hatice Germen ^c   Uysal, Bülent ^d   Erdeve, Ömer ^e   Dilmen, Ugur ^a,f  

^a Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Children Research Hospital   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e ANKARA UNIVERSITY   (Turkey)

^f YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Etanercept; Necrotizing enterocolitis; Tumor necrosis factor

Indexed keywords

ETANERCEPT; FREE RADICAL; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; MALONALDEHYDE; PLACEBO; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERCAPNIA; HYPEROXIA; HYPOTHERMIA; INFLAMMATION; INTESTINE; NECROTIZING ENTEROCOLITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE INJURY; TISSUE PREPARATION;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; MALONDIALDEHYDE; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892606356     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-013-3415-4     Document Type: Article

References (34)

1. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL (1991) Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 119:630-638
2. Holman RC, Stoll BJ, Curns AT, Yorita KL, Steiner CA, Schonberger LB (2006) Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol 20:498-506
3. Berman L, Moss RL (2011) Necrotizing enterocolitis: an update. Semin Fetal Neonatal Med 16:145-150
4. Hunter CJ, Upperman JS, Ford HR, Camerini V (2008) Understanding the susceptibility of the premature infant to necrotizing enterocolitis. Pediatr Res 63:117-123
5. Caplan MS, MacKendrick W (1993) Necrotizing enterocolitis: a review of pathogenetic mechanism and implications for prevention. Pediatr Pathol 13:357-369
6. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA (2000) Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 97:6043-6048
7. Halpern MD, Holubec H, Dominiguez JA et al (2002) Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 51:733-739
8. Edelson MB, Bagwell CE, Rozycki HJ (1999) Circulating pro- and counter inflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103:771-776
9. McElroy SJ, Prince LS, Weitkamp JH, Reese J, Slaughter JC, Polk DB (2011) Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 301:656-666
10. Sandborn WJ (2005) New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 5:10-18
11. Guven A, Gundogdu G, Vurucu S et al (2009) Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 44:1730-1735
12. Kumral A, Yesilirmak DC, Tugyan K et al (2010) Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis. J Pediatr Surg 45:483-489
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
14. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
15. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
16. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500
17. Nadler EP, Dickinson E, Knisely A et al (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 92:71-77
18. Caplan MS, Sun XM, Hseuh W, Hageman JR (1990) Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116:960-964
19. Afrazi A, Sodhi CP, Richardson W et al (2011) New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond. Pediatr Res 69:183-188
20. Paiotti AP, Miszputen SJ, Oshima CT, Artigiani Neto R, Ribeiro DA, Franco M (2011) Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression. J Mol Histol 42:443-450
21. De Plaen IG, Liu SX, Tian R et al (2007) Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 61:716-721
22. Travadi J, Patole S, Charles A, Dvorak B, Doherty D, Simmer K (2006) Pentoxifylline reduces the incidence and severity of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 60:185-189
23. Erdener D, Bakirtas F, Alkanat M, Mutaf I, Habif S, Bayindir O (2004) Pentoxifylline does not prevent hypoxia/reoxygenation-induced necrotizing enterocolitis. An experimental study. Biol Neonate 86:29-33
24. Halpern MD, Clark JA, Saunders TA et al (2006) Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol 290:757-764
25. Seitz G, Warmann SW, Guglielmetti A et al (2005) Protective effect of tumor necrosis factor alpha antibody on experimental necrotizing enterocolitis in the rat. J Pediatr Surg 40:1440-1445
26. Van Haver ER, Sangild PT, Oste M, Siggers JL, Weyns AL, Van Ginneken CJ (2009) Diet-dependent mucosal colonization and interleukin-1beta responses in preterm pigs susceptible to necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 49:90-98
27. Mazzon E, Esposito E, Di Paola R et al (2008) Effect of tumour necrosis factor-a receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with Etanercept. Clin Exp Immunol 153:136-149
28. Guven A, Gundogdu G, Uysal B et al (2009) Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model. J Pediatr Surg 44:534-540
29. Heinrich P, Georg L, Petro EP (2006). Biochemie und Pathobiochemie (Springer-Lehrbuch) (German Edition). Berlin: Springer. p 123. ISBN 3-540-32680-4
30. Iborra M, Moret I, Rausell F et al (2011) Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem Soc Trans 39(4):1102-1106
31. Zhang XP, Lin Q, Zhou YF (2007) Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 52:1199-1205
32. Tsujimoto M, Yokota S, Vilcek J, Weissmann G (1986) Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun 137:1094-1100
33. Valenzuela A (1991) The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 48:301-309
34. Yurttutan S, Ozdemir R, Canpolat FE et al (2013) Protective effects of colchicine in an experimental model of necrotizing enterocolitis in neonatal rats. J Surg Res 183:156-162